As of June 27, 2026, Lakefront Biotherapeutics NV (LKFT) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. Lakefront Biotherapeutics NV has a market capitalization of $1.87B, 65.90M shares outstanding.
Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.
📊 Score Breakdown
🔄Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for LKFT.
💹 Market Data
Market Cap$1.87B
Shares Outstanding65.90M
Float44.54M
Cash$3.48B
Debt$7.50M
Short InterestN/A
🏛 Institutional Holdings
22.7% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
📉 Short Interest
Short Interest2.18M
Days to Cover9.7
% of Float4.9%
FINRA data as of Jun 15, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
Track LKFT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LKFT — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
🔬 More Research for LKFT
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.